Author： Gourlet P. Rathe J. De Neef P. Cnudde J. Vandermeers-Piret M.-C. Waelbroeck M. Robberecht P.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.354, Iss.1, 1998-07, pp. : 105-111
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
VIP and PACAP in pain and inflammation
Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. :
Access to resources
Recommend
VIP and PACAP: very important in pain?
By Dickinson T. Fleetwood-Walker S.M.
Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. :
The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?
Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. :
Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Current Pharmaceutical Design, Vol. 17, Iss. 10, 2011-04 ,pp. :